<div id="readability-page-1"><div> <div> Shareholders should contact the firm immediately as there may be limited time to enforce your rights. , /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Nicolet Bankshares, Inc. (NYSE: NIC)'s merger with MidWestOne Financial Group, Inc. If you are a Nicolet shareholder, click here to learn more about your rights and options. Akero Therapeutics, Inc. (NASDAQ: AKRO)'s sale Novo Nordisk A/S. Under the terms of the proposed transaction, Akero shareholders will receive $54.00 per share in cash, and a non-transferable Contingent Value Right entitling its holder to receive a cash payment of $6.00 per share upon full U.S. regulatory approval of efruxifermin by June 30, 2031. If you are an Akero shareholder, click here to learn more about your rights and options. Barinthus Biotherapeutics plc (NASDAQ: BRNS)'s merger with Clywedog Therapeutics, Inc. Under the terms of the agreement, Barinthus shareholders will receive one share of common stock in the new combined company for each American Depositary Share or ordinary share owned. If you are a Barinthus shareholder, click here to learn more about your rights and options. Halper Sadeh LLC may seek increased consideration for shareholders, additional disclosures and information concerning the proposed transaction, or other relief and benefits on behalf of shareholders. We would handle the action on a contingent fee basis, whereby you would not be responsible for out-of-pocket payment of our legal fees or expenses. Shareholders are encouraged to contact the firm free of charge to discuss their legal rights and options. Please call Daniel Sadeh or Zachary Halper at (212) 763-0060 or email [email protected] or [email protected]. Halper Sadeh LLC represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors. Attorney Advertising. Prior results do not guarantee a similar outcome. Contact Information: Halper Sadeh LLC Daniel Sadeh, Esq. Zachary Halper, Esq. (212) 763-0060 [email protected] [email protected] https://www.halpersadeh.com SOURCE Halper Sadeh LLP <img src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjUxMTEyJk5ld3NJdGVtSWQ9TlkyMjY0NSZUcmFuc21pc3Npb25fSWQ9MjAyNTExMTIxMzU1UFJfTkVXU19VU1BSX19fX19OWTIyNjQ1?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" original-src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjUxMTEyJk5ld3NJdGVtSWQ9TlkyMjY0NSZUcmFuc21pc3Npb25fSWQ9MjAyNTExMTIxMzU1UFJfTkVXU19VU1BSX19fX19OWTIyNjQ1"/></div> </div></div>

BRNS

AKRO

Halper Sadeh LLC, an investor rights law firm, is investigating potential violations of federal securities laws involving Nicolet Bankshares, Inc. (NYSE: NIC), Akero Therapeutics, Inc. (NASDAQ: AKRO), and Barinthus Biotherapeutics plc (NASDAQ: BRNS). Shareholders are encouraged to contact the firm to discuss their rights and options regarding these companies' mergers and sales. The firm may seek increased consideration for shareholders and offers legal services on a contingent fee basis. Interested parties can reach out to Halper Sadeh LLC for more information.

13:55 ET Halper Sadeh LLC Encourages NIC, AKRO, BRNS Shareholders to Contact the Firm to Discuss Their Rights